ND-646, another allosteric inhibitor of ACC1 and ACC2, reduces tumor growth in NSCLC subcutaneous xenografts, suggesting potential avenues for therapeutic application.1291. Here, BCL2A1 is linked to non-small cell lung carcinoma.